GO
Loading...

Drug Retail

More

  • Intercept CEO: NASH epidemic of liver disease  Friday, 14 Nov 2014 | 3:16 PM ET

    Intercept Pharmaceuticals CEO Mark Pruzanski, provides insight to his company's efforts to tackle NASH, or nonalcoholic steatohepatitis, saying over 10 percent of the U.S. population is thought to have NASH. Pruzanski also weighs in on being a public company.

  • Lots of risk in biotech: Pro  Monday, 10 Nov 2014 | 2:22 PM ET

    Discussing warning signs from Dendreon, and other worrisome companies, with Les Funtleyder, E Square Asset Management.

  • Dendreon declares bankruptcy  Monday, 10 Nov 2014 | 2:18 PM ET

    Joseph Pantginis, Roth Capital, has been negative on Dendreon for a long time, ahead of the drugmaker's bankruptcy protection filing.

  • CHICAGO, Nov 6- A Chicago court on Thursday rejected Walgreens' move to block all disclosures of what the drugstore chain deems confidential information in a defamation lawsuit filed by its former chief financial officer. Cook County Circuit Court Judge Franklin Valderrama said Walgreens, the largest U.S. drugstore chain operator, failed to convince him that...

  • CHICAGO, Nov 6- A Chicago court on Thursday rejected Walgreens' move to block disclosures of what the drugstore chain deems confidential information in a defamation lawsuit filed by its former chief financial officer. Cook County Circuit Court Judge Franklin Valderrama said Walgreens, the largest U.S. drugstore chain operator, failed to convince him that all...

  • CHICAGO, Nov 4- CVS Health Corp reported slightly higher-than-expected quarterly results on Tuesday, helped by growth in specialty pharmacy sales and new client additions in its pharmacy benefits business. Net income at CVS, which operates the No. 2 U.S. drugstore chain and a major pharmacy benefits management business, fell to $948 million, or 81 cents per share,...

  • Supermarket sweep: What could lift Kroger shares Monday, 3 Nov 2014 | 12:37 PM ET
    A shopper outside a Kroger supermarket in Peoria, Illinois.

    Kroger has delivered 43 straight quarters of rising sales at stores open at least a year.

  • Apple CEO fires back as retailers block Pay Tuesday, 28 Oct 2014 | 1:11 AM ET

    LAGUNA BEACH, Calif., Oct 27- Apple Inc CEO Tim Cook fired back at CVS and Rite Aid on Monday after the drugstore chains blocked the iPhone maker's mobile payments service, saying there were plenty of other retailers around the world to sign up. It already totes up more transactions than all other "contactless" payment methods combined, Cook said, citing Visa and...

  • CHICAGO, Oct 27- U.S. drugstore chain Rite Aid Corp will ban Apple Inc's new electronic payments service in its 4,572 stores as it commits to joining a consortium of other large retailers developing a rival payments system. The rival system, called Current C, is being developed by Merchants Customer Exchange, a consortium of merchants that includes Rite Aid and...

  • Drugmakers want indemnity  Thursday, 23 Oct 2014 | 1:38 PM ET

    Drug companies may be looking for legal protection amid a massive demand for Ebola vaccines, reports CNBC's Meg Tirrell.

  • Former Walgreen CFO sues company for defamation Friday, 17 Oct 2014 | 7:59 AM ET

    Walgreen's former CFO sued the drugstore operator, alleging executives defamed him in news reports that blamed him for errors in its forecast.

  • GW Pharma: Focused on epilepsy  Tuesday, 14 Oct 2014 | 5:22 PM ET

    GW Pharma shares are down sharply after a study of its treatment for ulcerative colitis missed its primary endpoint in a mid-stage trial. GW Pharmaceuticals CEO Justin Gover, says the company's main focus is on its product for epilepsy.

  • Cannabis Expo: Pet food & more  Monday, 13 Oct 2014 | 8:57 AM ET

    CNBC's Kate Rogers reports from the East Coast Cannabis Business Expo, on one pot entrepreneur taking CBD, which is an extract of the hemp plant, and putting it in pet food.

  • Weed, Inc.: The business of legal marijuana  Thursday, 9 Oct 2014 | 7:00 AM ET

    Medical marijuana, which is legal in 23 states and Washington, D.C., and recreational marijuana -- legal in Colorado and Washington State -- bring dispensaries and states healthy revenues, via taxes and fees. Watch a 90-second overview of the business of legal marijuana by the numbers.

  • Oct 8- Canadian pharmacy chain Jean Coutu Group Inc reported a 3 percent rise in quarterly revenue as an increase in the number of franchised stores helped offset the impact of higher sales of generic drugs. Price-controls for generic drugs, aimed at cutting costs for government and private health programs, have also hurt Jean Coutu and rivals such as Shoppers...

  • Jean Coutu's sales rise 3 pct Wednesday, 8 Oct 2014 | 7:20 AM ET

    Oct 8- Canadian pharmacy chain Jean Coutu Group Inc reported higher quarterly sales, helped by demand for generic drugs and the expansion of its network of franchised stores. Net profit fell to C $53.6 million, or 28 Canadian cents per share, in the quarter ended Aug. 30, from C $208.2 million, or 99 Canadian cents per share, a year earlier. The company had reported a gain...

  • Oct 1- Express Scripts Holding Co, the largest U.S. pharmacy benefit manager, said Walgreen Co would sell prescription drugs under its two Medicare Part D plans for 2015..

  • Sept 30- U.S. drugstore chain Walgreen Co said lower insurer payments for prescriptions amid increased competition, and a rise in generic drug prices would continue to hurt margins in the current quarter, pressing its shares. Pharmacy chains such as Walgreen are contracted with health insurers and others that operate Medicare Part D drug plans.

  • Sept 30- U.S. drugstore chain operator Walgreen Co reported its biggest jump in quarterly sales in three years, helped by higher prescription sales, sending its shares up more than 3 percent in premarket trading. Walgreen ended the year with a record 856 million filled prescriptions.

  • Sept 30- U.S. drugstore chain operator Walgreen Co reported a 6.2 percent rise in quarterly sales, helped by higher prescription sales, sending its shares up more than 3 percent in premarket trading.